Radiotherapy omission in low-risk hormone receptor–positive breast cancer: insights from a Korean single-center cohort
Haeyoung Kim · 2025
Read Radiotherapy omission in low-risk hormone receptor–positive breast cancer: insights from a Korean single-center cohort by Haeyoung Kim (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12770875.txt.
Description
Haeyoung Kim, writing alone, comments on skipping radiotherapy in low-risk breast cancer in this 2025 editorial. Removing the breast tumor and following with radiation has long been the standard for early disease. As hormone therapy spread, doctors have hunted for a low-risk group that could safely skip radiation.
Kim reviews the major trials and pooled analyses, which agree that even the lowest-risk patients face more local recurrence without radiation. The editorial discusses a new Korean single-center report on a narrow group: postmenopausal women with small, low-grade, hormone-positive tumors and a low growth marker. Careful thought is still required before omitting radiation, Kim concludes.
Catalog record
| CREATOR | Haeyoung Kim |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 6 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |